Prosecution Insights
Last updated: July 17, 2026
Application No. 18/746,164

ELECTROOSMOTIC PUMP

Non-Final OA §102
Filed
Jun 18, 2024
Priority
Dec 24, 2021 — RE 10-2021-0187463 +1 more
Examiner
PONTON, JAMES D
Art Unit
Tech Center
Assignee
Ipv
OA Round
1 (Non-Final)
80%
Grant Probability
Favorable
1-2
OA Rounds
9m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allowance Rate
449 granted / 560 resolved
+20.2% vs TC avg
Strong +33% interview lift
Without
With
+33.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
38 currently pending
Career history
588
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
60.2%
+20.2% vs TC avg
§102
5.7%
-34.3% vs TC avg
§112
27.1%
-12.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 560 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of pre-AIA 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kim et al. (US 2019/0184095 A1), hereafter “Kim”. As to claim 1, Kim discloses an electroosmotic pump (see Fig. 5) comprising: a housing (7) that provides an inner space (see annotated Fig. 5 below) for containing a fluid therein and has a shaft hole (annotated below) connecting the inner space to an outer space thereof; and a shaft assembly (1, 17) that covers the shaft hole from an outside of the housing (see Fig. 5), is connected to the housing, and is capable of changing a shape in a longitudinal direction by a flow of the fluid passing through the shaft hole (para 0046-0047, 0059; the examiner notes that “capable of changing a shape in a longitudinal direction by a flow of the fluid…” is merely a description of the capabilities of the shaft assembly – it is clear that the diaphragm is flexible and therefore capable of changing in shape as claimed). PNG media_image1.png 681 645 media_image1.png Greyscale Claims 1 and 5 are rejected under a different interpretation of Kim below As to claim 1, Kim discloses electroosmotic pump (see Fig. 5) comprising: a housing (19) that provides an inner space (annotated below) for containing a fluid therein and has a shaft hole (leftside opening of 19 that leads to space between 17) connecting the inner space to an outer space thereof (see Fig. 5); and a shaft assembly (1, 17) that covers the shaft hole from an outside of the housing, is connected to the housing, and is capable of changing a shape in a longitudinal direction by a flow of the fluid passing through the shaft hole (para 0046-0047, 0059; the examiner notes that “capable of changing a shape in a longitudinal direction by a flow of the fluid…” is merely a description of the capabilities of the shaft assembly – it is clear that the diaphragm is flexible and therefore capable of changing in shape as claimed). PNG media_image2.png 558 799 media_image2.png Greyscale As to claim 5, Kim discloses the electroosmotic pump of claim 1, further comprising a membrane (25) that divides the inner space into a first space (space to left of membrane 25) and a second space (space to right of membrane 25), wherein the flow of the fluid passing through the shaft hole depends on a flow of the fluid passing through the membrane (para 0052, 0063, 0064). Claim(s) 1 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Hobson (US 6113366). As to claim 1, Hobson discloses an electroosmotic pump (see Figs. 1-3) comprising: a housing (12) that provides an inner space (interior of 12, including the neck 21) for containing a fluid therein and has a shaft hole (top-most opening of neck 21) connecting the inner space to an outer space thereof; and a shaft assembly (11) that covers the shaft hole from an outside of the housing (Figs. 1-3), is connected to the housing (via threads; see para beginning line 40 col. 2), and is capable of changing a shape in a longitudinal direction by a flow of the fluid passing through the shaft hole ()via bellows 24 expanding; the examiner notes that “capable of changing a shape in a longitudinal direction by a flow of the fluid…” is merely a description of the capabilities of the shaft assembly – it is clear that the bellows 24 are capable of changing in shape as claimed). Allowable Subject Matter Claims 2-4 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: As to claim 2, while Kim discloses the electroosmotic pump of claim 1 as described above, and further discloses wherein the shaft assembly (1, 17) comprises: an expansion/contraction member (17) that forms an expansion/contraction space communicating with the shaft hole para (Fig. 5, para 0046-0047, 0059); but is silent to a rod member that is coupled to the expansion/contraction member and is formed to extend while sharing a longitudinal central axis with the expansion/contraction member in combination. Claims 3-4 depend from claim 2. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to James D Ponton whose telephone number is (571)272-1001. The examiner can normally be reached M-F 9am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Chelsea Stinson can be reached at 571-270-1744. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /James D Ponton/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Jun 18, 2024
Application Filed
Jun 30, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678591
CATHETERS AND METHODS FOR MAKING THEM
4y 10m to grant Granted Jul 14, 2026
Patent 12673165
PRECISION LOW-DOSE,LOW-WASTE SYRINGES AND ERGONOMIC ATTACHMENTS THEREFOR
4y 0m to grant Granted Jul 07, 2026
Patent 12661492
SANITIZING CAPS FOR MEDICAL CONNECTORS
5y 9m to grant Granted Jun 23, 2026
Patent 12653992
METHODS AND DEVICES FOR TREATING A DISEASE WITH BIOTHERAPEUTICS
4y 3m to grant Granted Jun 16, 2026
Patent 12653571
TAP BLOCK INJECTION DEVICE
4y 0m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
80%
Grant Probability
99%
With Interview (+33.4%)
2y 10m (~9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 560 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month